Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-950 + Pegasys + Copegus in Hepatitis C
NCT00262483Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of telaprevir in hepatitis C virus infection, sponsored by Vertex Pharmaceuticals. Started Dec 2005; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00262483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262483.